Loading clinical trials...
Loading clinical trials...
Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
University of Minnesota
Minneapolis, Minnesota, United States
Start Date
January 7, 2026
Primary Completion Date
January 31, 2028
Completion Date
January 31, 2028
Last Updated
January 14, 2026
400
ESTIMATED participants
2-Week Home Monitoring
DIAGNOSTIC_TEST
6-Week Home Monitoring
DIAGNOSTIC_TEST
Lead Sponsor
University of Minnesota
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions